Characteristics of Pediatric Patients with Congenital Heart Disease Undergoing Transcatheter Defect Closure at Adam Malik General Hospital, Medan
DOI:
https://doi.org/10.36911/pannmed.v21i1.2434Keywords:
children, transcatheter closure, congenital heart disease, VSD, ASD, PDAAbstract
Introduction. Transcatheter closure has become an increasingly common non-surgical intervention for Ventricular Septal Defect (VSD), Atrial Septal Defect (ASD), and Patent Ductus Arteriosus (PDA). However, data on the characteristics of patients undergoing transcatheter closure in North Sumatra remain limited. Objective. This study aimed to describe the demographic and clinical characteristics of pediatric patients undergoing transcatheter closure procedures. Methods. A retrospective descriptive study was conducted using medical records of pediatric patients with congenital heart disease who underwent transcatheter closure at Adam Malik General Hospital, Medan. Patient characteristics including sex, age, nutritional status, clinical presentation, defect type and size, and occluder device type were analyzed. Results. A total of 108 patients met the inclusion and exclusion criteria. The majority were female (54,6%) and aged 12-59 months (50,9%), with normal nutritional status (52.8%). VSD was the most common defect (68,5%), predominantly of moderate size (57,4%). Most patients were classified as ROSS/NYHA class II (70,4%). The AMVO occluder was the most frequently used device (67,6%), with size 8/6 being the most common. Conclusion. Most pediatric patients undergoing transcatheter closure were female, aged 1–3 years, had normal nutritional status, and presented with moderate VSD classified as ROSS/NYHA class II. The AMVO occluder, particularly size 8/6, was the most frequently utilized device.
References
Ossa Galvis MM, Bhakta RT, Tarmahomed A, et al. Cyanotic heart disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK500001/
Liu Y, Chen S, Zühlke L, et al. Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455–463. doi:10.1093/ije/dyz009
Azali R, Hariyanto D, Yani F. Overview of risk factors for toddlers with congenital heart disease suffering from pneumonia at Dr. M. Djamil General Hospital, Padang, Indonesia. Bioscientia Medicina. 2023;6(17). doi:10.37275/bsm.v6i17.717
Djer MM, Saputro DD, Putra ST, Idris NS. Transcatheter closure of patent ductus arteriosus: 11 years of clinical experience in Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Pediatr Cardiol. 2015;36:1070–1074. doi:10.1007/s00246-015-1128-2
Jiang D, Han B, Zhao L, et al. Transcatheter device closure of perimembranous and intracristal ventricular septal defects in children: medium- and long-term results. J Am Heart Assoc. 2021;10(11):e020417. doi:10.1161/JAHA.120.020417
Putra ST, Djer MM, Idris NS, Samion H, Sastroasmoro S. Transcatheter closure of atrial septal defects in a center with limited resources: outcomes and short-term follow-up. Iran J Pediatr. 2015;25(6):e3906. doi:10.5812/ijp.3906
O’Byrne ML, Shinohara RT, Grant EK, Kanter JP, Gillespie MJ, Dori Y, et al. Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer septal occluder device: an observational study using data from the Pediatric Health Information Systems Database. Am Heart J. 2017;192:85–97. doi:10.1016/j.ahj.2017.07.012
Turner ME, Bouhout I, Petit CJ, Kalfa D. Transcatheter closure of atrial and ventricular septal defects: JACC focus seminar. J Am Coll Cardiol. 2022;79(22):2247–2258. doi:10.1016/j.jacc.2021.08.082
Zhou Z, Gu Y, Zheng H, Li S, Xu L, Liu Q, et al. Transcatheter closure of patent ductus arteriosus via different approaches. Front Cardiovasc Med. 2022;8:797905. doi:10.3389/fcvm.2021.797905
Park MK, Salamat M. Park’s pediatric cardiology for practitioners. 7th ed. Philadelphia: Elsevier; 2021.
Melekoglu AN, Baspinar O. Transcatheter cardiac interventions in neonates with congenital heart disease: a single centre experience. J Int Med Res. 2019;47(2):615–625. doi:10.1177/0300060518806111
Ablisar AA. Profil pasien anak penderita penyakit jantung bawaan asianotik yang melakukan penutupan secara transkateter di Rumah Sakit Umum Pusat Haji Adam Malik Medan pada tahun 2015–2017 [skripsi]. Medan: Universitas Sumatera Utara; 2018.
Salim M, Utamayasa IKA, Irawan R, Irwanto, Putera AM, Ardiana M. The effect of cardiac catheterization intervention on the nutritional status of children with acyanotic congenital heart disease. Pharmacogn J. 2023;15(2):338–342. doi:10.5530/pj.2023.15.51
Zhang M, Wang L, Huang R, Sun C, Bao N, Xu Z. Risk factors of malnutrition in Chinese children with congenital heart defect. BMC Pediatr. 2020;20(1):1–7. doi:10.1186/s12887-020-02124-7
Song J. Percutaneous transcatheter closure of congenital ventricular septal defects. Korean Circ J. 2023;53(3):134–150. doi:10.4070/kcj.2022.0336
